Silvercrest Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.3M | Buy |
90,091
+16,669
| +23% | +$9.05M | 0.32% | 82 |
|
|
2025
Q4 | $42.5M | Sell |
73,422
-11,165
| -13% | -$6.31M | 0.29% | 96 |
|
|
2025
Q3 | $41M | Buy |
84,587
+43,147
| +104% | +$20.1M | 0.27% | 112 |
|
|
2025
Q2 | $16.8M | Sell |
41,440
-410
| -1% | -$171K | 0.11% | 227 |
|
|
2025
Q1 | $20.8M | Buy |
41,850
+807
| +2% | +$437K | 0.15% | 179 |
|
|
2024
Q4 | $21.4M | Sell |
41,043
-480
| -1% | -$264K | 0.14% | 177 |
|
|
2024
Q3 | $25.7M | Buy |
41,523
+11
| +0% | +$6.51K | 0.17% | 168 |
|
|
2024
Q2 | $23M | Sell |
41,512
-4,118
| -9% | -$2.36M | 0.16% | 170 |
|
|
2024
Q1 | $26.5M | Buy |
45,630
+1,053
| +2% | +$591K | 0.18% | 158 |
|
|
2023
Q4 | $23.7M | Buy |
44,577
+958
| +2% | +$464K | 0.17% | 162 |
|
|
2023
Q3 | $22.1M | Buy |
43,619
+106
| +0.2% | +$56.5K | 0.17% | 162 |
|
|
2023
Q2 | $22.7M | Buy |
43,513
+1,435
| +3% | +$774K | 0.16% | 163 |
|
|
2023
Q1 | $24.3M | Sell |
42,078
-129
| -0.3% | -$72.7K | 0.18% | 148 |
|
|
2022
Q4 | $23.2M | Buy |
42,207
+460
| +1% | +$244K | 0.18% | 149 |
|
|
2022
Q3 | $21.2M | Sell |
41,747
-1,036
| -2% | -$580K | 0.17% | 156 |
|
|
2022
Q2 | $23.2M | Sell |
42,783
-2,224
| -5% | -$1.22M | 0.18% | 155 |
|
|
2022
Q1 | $26.6M | Buy |
45,007
+662
| +1% | +$380K | 0.17% | 160 |
|
|
2021
Q4 | $29.6M | Sell |
44,345
-1,151
| -3% | -$719K | 0.19% | 145 |
|
|
2021
Q3 | $26M | Sell |
45,496
-310
| -0.7% | -$170K | 0.18% | 153 |
|
|
2021
Q2 | $23.1M | Sell |
45,806
-284
| -0.6% | -$134K | 0.15% | 174 |
|
|
2021
Q1 | $21M | Buy |
46,090
+9,358
| +25% | +$4.47M | 0.14% | 178 |
|
|
2020
Q4 | $17.1M | Sell |
36,732
-1,150
| -3% | -$539K | 0.12% | 184 |
|
|
2020
Q3 | $16.7M | Sell |
37,882
-352
| -0.9% | -$145K | 0.14% | 165 |
|
|
2020
Q2 | $13.9M | Buy |
38,234
+1,327
| +4% | +$445K | 0.12% | 174 |
|
|
2020
Q1 | $10.5M | Sell |
36,907
-180
| -0.5% | -$56.8K | 0.11% | 187 |
|
|
2019
Q4 | $12M | Sell |
37,087
-213
| -0.6% | -$64.6K | 0.09% | 212 |
|
|
2019
Q3 | $10.9M | Hold |
37,300
| – | – | 0.09% | 215 |
|
|
2019
Q2 | $11M | Buy |
37,300
+389
| +1% | +$107K | 0.1% | 170 |
|
|
2019
Q1 | $10.1M | Sell |
36,911
-553
| -1% | -$138K | 0.1% | 173 |
|
|
2018
Q4 | $8.38M | Sell |
37,464
-194
| -0.5% | -$45.5K | 0.09% | 181 |
|
|
2018
Q3 | $9.19M | Sell |
37,658
-56
| -0.1% | -$12.9K | 0.08% | 186 |
|
|
2018
Q2 | $7.81M | Buy |
37,714
+692
| +2% | +$147K | 0.07% | 202 |
|
|
2018
Q1 | $7.64M | Sell |
37,022
-97
| -0.3% | -$20.4K | 0.07% | 198 |
|
|
2017
Q4 | $7.05M | Buy |
37,119
+1,482
| +4% | +$284K | 0.07% | 207 |
|
|
2017
Q3 | $6.74M | Buy |
35,637
+675
| +2% | +$122K | 0.07% | 200 |
|
|
2017
Q2 | $6.1M | Buy |
34,962
+172
| +0.5% | +$28.9K | 0.07% | 205 |
|
|
2017
Q1 | $5.34M | Sell |
34,790
-676
| -2% | -$103K | 0.06% | 216 |
|
|
2016
Q4 | $5M | Sell |
35,466
-849
| -2% | -$125K | 0.06% | 219 |
|
|
2016
Q3 | $5.78M | Sell |
36,315
-988
| -3% | -$152K | 0.07% | 207 |
|
|
2016
Q2 | $5.51M | Buy |
37,303
+832
| +2% | +$123K | 0.07% | 203 |
|
|
2016
Q1 | $5.16M | Sell |
36,471
-1,603
| -4% | -$215K | 0.07% | 199 |
|
|
2015
Q4 | $5.4M | Buy |
38,074
+15,273
| +67% | +$2.04M | 0.07% | 206 |
|
|
2015
Q3 | $2.79M | Sell |
22,801
-15,814
| -41% | -$2.06M | 0.04% | 236 |
|
|
2015
Q2 | $5.01M | Buy |
38,615
+16,450
| +74% | +$2.14M | 0.07% | 222 |
|
|
2015
Q1 | $2.98M | Sell |
22,165
-1,625
| -7% | -$209K | 0.04% | 237 |
|
|
2014
Q4 | $2.98M | Buy |
23,790
+2,000
| +9% | +$243K | 0.04% | 244 |
|
|
2014
Q3 | $2.65M | Hold |
21,790
| – | – | 0.04% | 247 |
|
|
2014
Q2 | $2.57M | Buy |
21,790
+2,792
| +15% | +$329K | 0.04% | 250 |
|
|
2014
Q1 | $2.28M | Sell |
18,998
-200
| -1% | -$23.8K | 0.04% | 252 |
|
|
2013
Q4 | $2.14M | Buy |
19,198
+741
| +4% | +$73.7K | 0.04% | 260 |
|
|
2013
Q3 | $1.7M | Buy |
18,457
+2,170
| +13% | +$196K | 0.03% | 269 |
|
|
2013
Q2 | $1.38M | Buy |
+16,287
| New | +$1.36M | 0.03% | 277 |
|
Other funds holding TMO
VCM
Silvercrest Asset Management's TMO Position: Q1 2026 in Review
Silvercrest Asset Management increased its Thermo Fisher Scientific (TMO) stake by 23% in Q1 2026, buying an estimated $9.05M and bringing the position to 90,091 shares worth $44.3M. The position accounts for 0.32% of the portfolio, ranked #82.
Silvercrest Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Silvercrest Asset Management held 90,091 shares of Thermo Fisher Scientific worth $44.3M as of Q1 2026.
- Silvercrest Asset Management bought 16,669 Thermo Fisher Scientific shares in Q1 2026, an estimated $9.05M.
- Thermo Fisher Scientific made up 0.32% of Silvercrest Asset Management's portfolio in Q1 2026, its #82 holding.
- Silvercrest Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.